841219934	841219934	CD	B-NP	O
|	|	NN	I-NP	O
NH	NH	NN	I-NP	O
|	|	NN	I-NP	O
12760693	12760693	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0459166	0459166	CD	B-NP	O
|	|	CC	I-NP	O
5/25/2006	5/25/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/29/2006	4/29/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/7/2006	5/7/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SECKMAN	SECKMAN	NNP	B-NP	O
,	,	,	O	O
JEREMIAH	JEREMIAH	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
jaw	jaw	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Harpst	Harpst	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
who	who	WP	B-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
worsened	worsen	VBD	B-VP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
sensation	sensation	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
gets	get	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
increases	increase	NNS	I-NP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
some	some	DT	B-NP	O
jaw	jaw	NN	I-NP	O
soreness	soreness	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
commonly	commonly	RB	B-ADVP	O
feels	feel	VBZ	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
gets	get	VBZ	B-VP	O
some	some	DT	B-NP	O
pain	pain	NN	I-NP	O
under	under	IN	B-PP	O
her	her	PRP$	B-NP	O
breasts	breast	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
increased	increase	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
or	or	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
claudication	claudication	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
worsens	worsen	VBZ	B-VP	O
in	in	IN	B-PP	O
cold	cold	JJ	B-NP	O
weather	weather	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
gets	get	VBZ	B-VP	O
up	up	RP	B-PRT	O
quickly	quickly	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
lightheaded	lightheaded	JJ	B-ADJP	O
but	but	CC	O	O
no	no	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
steady	steady	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
nausea	nausea	NN	I-NP	O
today	today	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
little	little	JJ	B-NP	O
bit	bit	NN	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
but	but	CC	O	O
nonbloody	nonbloody	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
colitis	colitis	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
new	new	JJ	I-NP	O
joint	joint	JJ	I-NP	O
pains	pain	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
with	with	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
status	status	NN	I-NP	O
post	post	VBP	B-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
1986	1986	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	VBP	B-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
had	have	VBD	I-VP	O
PCI	PCI	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
pelvic	pelvic	JJ	I-NP	I-protein
floor	floor	NN	I-NP	I-protein
suspension	suspension	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
lysis	lysis	NN	I-NP	O
of	of	IN	B-PP	O
adhesions	adhesion	NNS	B-NP	O
for	for	IN	B-PP	O
bowel	bowel	NN	B-NP	O
obstruction	obstruction	NN	I-NP	O
and	and	CC	I-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
Pravachol	Pravachol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
XR	XR	NN	I-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Asacol	Asacol	NNP	B-NP	O
1200	1200	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
cilostazol	cilostazol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
,	,	,	O	O
lorazepam	lorazepam	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	I-NP	O
midday	midday	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
allergies	allergy	NNS	B-NP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
cause	cause	VBP	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
causes	cause	VBZ	B-VP	O
angioedema	angioedema	NN	B-NP	O
,	,	,	O	O
tetracycline	tetracycline	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
H2	H2	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
+	+	SYM	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
in	in	IN	B-PP	O
1986	1986	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
drinking	drinking	NN	I-NP	O
currently	currently	RB	B-ADVP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
96.1	96.1	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/60	130/60	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
24	24	CD	I-NP	O
and	and	CC	O	O
saturating	saturate	VBG	B-VP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
stated	state	VBN	B-NP	O
age	age	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
anisocoria	anisocoria	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
,	,	,	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
and	and	CC	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
shows	show	VBZ	B-VP	O
V	V	NN	B-NP	O
pacing	pacing	NN	I-NP	O
with	with	IN	B-PP	O
underlined	underlined	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
29.2	29.2	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
and	and	CC	I-NP	O
troponins	troponin	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
performed	perform	VBN	B-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
atelectasis	atelectasis	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
reduced	reduce	VBN	I-NP	O
EF	EF	NN	I-NP	B-protein
,	,	,	O	O
hypokinetic	hypokinetic	JJ	B-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
dilated	dilated	JJ	B-NP	B-protein
RA	RA	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
AR	AR	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
PR	PR	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
MIBI	MIBI	NN	I-NP	B-DNA
performed	perform	VBN	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
10/2/2006	10/2/2006	CD	B-NP	O
,	,	,	O	O
later	later	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
improved	improved	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
slightly	slightly	RB	B-VP	O
increased	increase	VBD	I-VP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
clot	clot	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mild-to-moderate	mild-to-moderate	JJ	I-NP	O
decreased	decrease	VBN	I-NP	O
EF	EF	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TTE	TTE	NN	I-NP	O
with	with	IN	B-PP	O
bubble	bubble	NN	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
7/5/2006	7/5/2006	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
shunt	shunt	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
PFTs	PFT	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mixed	mix	VBN	I-NP	O
restrictive	restrictive	JJ	I-NP	O
and	and	CC	I-NP	O
obstructive	obstructive	JJ	I-NP	O
picture	picture	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
mild-to-moderate	mild-to-moderate	JJ	B-ADJP	O
in	in	IN	B-PP	O
severity	severity	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Prestage	Prestage	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
poorly	poorly	RB	I-VP	O
controlled	control	VBN	I-VP	O
despite	despite	IN	B-PP	O
extremely	extremely	RB	B-NP	O
high	high	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
beta-blockers	beta-blocker	NNS	B-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
digoxin	digoxin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	O
and	and	CC	I-NP	O
DC	DC	NN	I-NP	B-cell_type
cardioversion	cardioversion	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
V	V	NN	B-NP	O
paced	pace	VBN	B-VP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
for	for	IN	B-PP	O
remainder	remainder	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
her	her	PRP$	B-NP	O
DC	DC	NN	I-NP	B-cell_type
cardioversion	cardioversion	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypoxic	hypoxic	JJ	B-ADJP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
discussed	discuss	VBD	B-VP	O
below	below	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
MIBI	MIBI	NNP	I-NP	O
as	as	IN	B-SBAR	O
discussed	discuss	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
previous	previous	JJ	I-NP	O
interventions	intervention	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
thought	thought	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
manage	manage	VB	I-VP	O
her	her	PRP	B-NP	O
medically	medically	RB	B-ADVP	O
since	since	IN	B-SBAR	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
amenable	amenable	JJ	B-ADJP	O
to	to	TO	B-VP	O
intervention	intervention	VB	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
45	45	CD	B-NP	O
to	to	TO	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
marginally	marginally	RB	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
gentle	gentle	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
TTE	TTE	NN	I-NP	O
on	on	IN	B-PP	O
7/5/2006	7/5/2006	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
2002	2002	CD	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
her	her	PRP$	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
saturating	saturate	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
80s	80	NNS	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
desaturating	desaturate	VBG	B-VP	O
further	further	RBR	B-ADVP	O
on	on	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
ABG	ABG	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
7.48	7.48	CD	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
33	33	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pO2	pO2	NN	B-NP	O
52	52	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
carbon	carbon	NN	B-NP	O
monoxide	monoxide	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
methemoglobinemia	methemoglobinemia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
PFTs	PFT	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
as	as	RB	I-VP	O
described	describe	VBN	I-VP	O
above	above	IN	B-PP	O
.	.	.	O	O

With	With	IN	B-PP	O
a	a	DT	B-NP	O
gentle	gentle	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
more	more	JJR	B-NP	O
ambulation	ambulation	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
why	why	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
this	this	DT	B-NP	O
transient	transient	JJ	I-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
Advair	Advair	NNP	B-NP	O
and	and	CC	I-NP	O
Spiriva	Spiriva	NNP	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
these	these	DT	B-NP	O
made	make	VBN	B-VP	O
her	her	PRP	B-NP	O
feel	feel	VB	B-VP	O
better	good	JJR	B-ADJP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
these	these	DT	B-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
not	not	RB	O	O
then	then	RB	B-ADVP	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
stop	stop	VB	I-VP	O
them	them	PRP	B-NP	O
.	.	.	O	O

Also	Also	RB	B-VP	O
mentioned	mention	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
bubble	bubble	JJ	I-NP	O
study	study	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
shunt	shunt	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
sum	sum	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
plus	plus	CC	O	O
some	some	DT	B-NP	O
underlying	underlying	JJ	I-NP	O
COPD	COPD	NN	I-NP	O
plus	plus	CC	O	O
her	her	PRP$	B-NP	O
underlying	underlie	VBG	I-NP	O
small	small	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
improved	improve	VBN	I-VP	O
since	since	IN	B-PP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
PCI	PCI	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
cilostazol	cilostazol	NN	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

Endo	Endo	UH	B-INTJ	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
held	hold	VBD	B-VP	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
anticoagulants	anticoagulant	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
agents	agent	NNS	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
inhouse	inhouse	NN	B-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
metformin	metformin	NN	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Chafin	Chafin	NNP	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
as	as	RB	B-PP	O
usual	usual	JJ	B-ADJP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Majica	Majica	NNP	I-NP	O
office	office	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
PFTs	PFT	NNS	B-NP	B-protein
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
In	In	NNP	I-NP	O
Bingenu	Bingenu	NNP	I-NP	O
Na	Na	NNP	I-NP	O
Plama	Plama	NNP	I-NP	O
Leah	Leah	NNP	I-NP	O
on	on	IN	B-PP	O
10/9/2006	10/9/2006	CD	B-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
at	at	IN	B-PP	O
Thou	Thou	NNP	B-NP	O
Bernsing	Bernsing	NNP	I-NP	O
Also	Also	NNP	I-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chivers	Chiver	NNPS	I-NP	O
who	who	WP	B-NP	O
would	would	MD	B-VP	O
arrange	arrange	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
,	,	,	O	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
home	home	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
headache	headache	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lomotil	Lomotil	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
tabs	tab	NNS	I-NP	I-protein
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
four	four	CD	B-ADVP	O
times	time	NNS	I-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
lorazepam	lorazepam	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	I-NP	O
midday	midday	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
lorazepam	lorazepam	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
Pravachol	Pravachol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
XR	XR	NN	I-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Asacol	Asacol	NNP	B-NP	O
1200	1200	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
cilostazol	cilostazol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Spiriva	Spiriva	NNP	B-NP	O
18	18	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
Lovenox	Lovenox	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
subq	subq	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-3998047	9-3998047	CD	B-NP	O
PFFocus	PFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BUGLER	BUGLER	NNP	B-NP	O
,	,	,	O	O
SCOTT	SCOTT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
THIESSE	THIESSE	NNP	B-NP	O
,	,	,	O	O
HARVEY	HARVEY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6930949	6930949	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/5/06	5/5/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/5/06	5/5/06	CD	B-NP	O

